A new review led by the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) provides guidance on how to diagnose suspected multiple sclerosis (MS) in individuals under 18 and adults 50 years and older.
Drafted by an international committee of 19 MS experts from North America, Europe, and Latin America, the comprehensive review published online today in JAMA Neurology will help improve diagnostic accuracy in atypical presentations of the disease.
